IntraMed - Artículos - Endocarditis infecciosa
Diagnóstico y tratamiento | 06 MAY 13
Endocarditis infecciosa
Recomendaciones basadas en las guías de Europa y Estados Unidos para la profilaxis y el tratamiento de la endocarditis infecciosa.
Autor: Dres. Bruno Hoen, Xavier Duva N Engl J Med 2013;368:1425-33
INDICE:  1. Artículo | 2. Referencias
Referencias

1. Correa de Sa DD, Tleyjeh IM, Anavekar NS, et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2010;85:422-6. [Erratum, Mayo Clin Proc 2010;85:772.]
2. Duval X, Delahaye F, Alla F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 2012;59:1968-76.
3. Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis 2011;11:48.
4. Federspiel JJ, Stearns SC, Peppercorn AF, Chu VH, Fowler VG Jr. Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008. Arch Intern Med 2012; 172:363-5.
5. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary populationbased profile of 1536 patients in Australia. Eur Heart J 2010;31:1890-7.
6. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463-73.
7. Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012;54:1230-9.
8. Benito N, Miró JM, de Lazzari E, et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med 2009;150:586-94.
9. Tleyjeh IM, Abdel-Latif A, Rahbi H, et al. A systematic review of populationbased studies of infective endocarditis. Chest 2007;132:1025-35.
10. Fournier PE, Thuny F, Richet H, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 2010;51:131-40.
11. Houpikian P, Raoult D. Blood culturenegative endocarditis in a reference center:  etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005;84:162-73.
12. Stehbens WE, Delahunt B, Zuccollo JM. The histopathology of endocardial sclerosis. Cardiovasc Pathol 2000;9:161-73.
13. Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 2001;14:177-207.
14. Bannay A, Hoen B, Duval X, et al. The impact of valve surgery on short- and longterm mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 2011;32:2003-15.
15. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
16. Richet H, Casalta JP, Thuny F, et al. Development and assessment of a new early scoring system using non-specific clinical signs and biological results to identify children and adult patients with a high probability of infective endocarditis on admission. J Antimicrob Chemother 2008;62:1434-40.
17. Crawford MH, Durack DT. Clinical presentation of infective endocarditis. Cardiol Clin 2003;21:159-66.
18. Thuny F, Avierinos JF, Tribouilloy C, et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J 2007;28:1155-61.
19. Sonneville R, Mirabel M, Hajage D, et al. Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med 2011;39:1474-81.
20. Dickerman SA, Abrutyn E, Barsic B, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007;154:1086-94.
21. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005;112:69-75. [Erratum, Circulation 2005;112(9):e125.]
22. Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events The New England Journal of Medicine in infective endocarditis. J Am Coll Cardiol 2001;37:1069-76.
23. Duval X, Iung B, Klein I, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med 2010;152:497-504.
24. Corr P, Wright M, Handler LC. Endocarditis-related cerebral aneurysms: radiologic changes with treatment. AJNR Am J Neuroradiol 1995;16:745-8.
25. Peters PJ, Harrison T, Lennox JL. A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis 2006;6:742-8.
26. Greub G, Lepidi H, Rovery C, et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med 2005;118:230-8.
27. Lepidi H, Coulibaly B, Casalta JP, Raoult D. Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. J Infect Dis 2006;193:1711-7.
28. Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis- related mortality with a management- based approach. Arch Intern Med 2009;169:1290-8.
29. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111(23):e394-e434. [Errata, Circulation 2005;112:2373, 2007;115(15):e408, 116(21):e547, 2008;118(12):e497.]
30. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC): endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-413.
31. Gould FK, Denning DW, Elliott TS, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012;67:269-89. [Erratum, J Antimicrob Chemother 2012;67:1304.]
32. Morris AJ, Drinković D, Pottumarthy S, MacCulloch D, Kerr AR, West T. Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis 2005;41:187-94.
33. Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis 1995;21:1406-10.
34. Sexton DJ, Tenenbaum MJ, Wilson WR, et al. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Clin Infect Dis 1998;27:1470-4.
35. Olaison L, Schadewitz K. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 2002;34:159-66.
36. Gavaldà J, Len O, Miró JM, et al. Treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 2007;146:574-9.
37. Fernández-Hidalgo N, Almirante B, Gavaldà J, et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 2013 February 25 (Epub ahead of print).
38. Cosgrove SE, Vigliani GA, Fowler VG Jr, et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009;48:713-21.
39. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653-65.
40. Das I, Saluja T, Steeds R. Use of daptomycin in complicated cases of infective endocarditis. Eur J Clin Microbiol Infect Dis 2011;30:807-12.
41. Durante-Mangoni E, Casillo R, Bernardo M, et al. High-dose daptomycin for cardiac implantable electronic devicerelated infective endocarditis. Clin Infect Dis 2012;54:347-54.
42. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011;52:285-92.
43. Kang D-H, Kim Y-J, Kim S-H, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012;366:2466-73.
44. Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 1999;159:473-5.
45. Chan KL, Dumesnil JG, Cujec B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003;42:775-80.
46. Chan KL, Tam J, Dumesnil JG, et al. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis 2008;46:37-41.
47. Pepin J, Tremblay V, Bechard D, et al. Chronic antiplatelet therapy and mortality among patients with infective endocarditis. Clin Microbiol Infect 2009;15:193-9.
48. Snygg-Martin U, Rasmussen RV, Hassager C, Bruun NE, Andersson R, Olaison L. The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in leftsided infective endocarditis. Scand J Infect Dis 2011;43:899-904.
49. Anavekar NS, Tleyjeh IM, Anavekar NS, et al. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007;44:1180-6. [Erratum, Clin Infect Dis 2007;44:1398.]
 50. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-54. [Erratum, Circulation 2007;116(15):e376-e377.]
51. Richey R, Wray D, Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ 2008;336:770-1.
52. Thornhill MH, Dayer MJ, Forde JM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis:before and after study. BMJ 2011;342:d2392.
53. Desimone DC, Tleyjeh IM, Correa de Sa DD, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation 2012;126:60-4.
54. Heldman AW, Hartert TV, Ray SC, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996;101:68-76.
55. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 2011;32:2027-33.

Comentarios

Usted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí
Bioing. Gonzalo Quinteros   Hace 8 meses
Que opinan del uso de antibióticos de última generación como el Linezolid para SARM en endocartidis. Saludos.
Dr. JOSE MARIO GARCIA GONZALEZ   Hace 1 año
Me parece excelente repaso y felicito a los autores por este buen repaso GRACIAS.
Dr. Ernesto Cupido   Hace 1 año

Siempre buscar focos infecciosos crónicos de cavidad bucal,no dejar nada de lado.
Dr. Gabriel Campoamor   Hace 1 año
Cual seria la profilaxis antibiotica para prevenir endocarditis infecciosa en un paciente que se va a someter a un tratamiento odontologico (sea quirurgico o no) Que medicación , que dosis y durante cuanto tiempo ? Muchas gracias
Dr. Italo Roberto Ricco   Hace 1 año
Muy buen repaso recordatorio general. Es interesante recordar que la endocarditis brucelar es siempre quirúrgica.
Dr. Carlos Pérez Fernández   Hace 1 año
Felicitaciones a los autores.
Dr. Esteban Alberto Serrano   Hace 1 año
La endocarditis infecciosa es una identidad que sigue afectando y muy especialmente a los pacientes de la población Hospitalaria a nivel público donde vemos muchos casos de distinta gravedad y diferentes entidades anatómicas.
Es fundamental además del tratamiento ATB específico, la remoción quirúrgica de las vegetaciones y abscesos valvulares y a veces en zonas cardíacas de muy dificil abordaje.
Este trabajo resulta muy útil y felicito a los autores.
Dr. Gustavo Ignacio Flores   Hace 1 año
ME PARECE APORTAR EL DATO SOBRE UNA PACIENTE CON SINDROME FEBRIL PROLONGADO Y CON HEMOCULTIVOS POSITIVOS A STAFILOCOCCUS METICILINO SENSIBLE. LO NOVEDOSO ES PRESENTABA DOS VEGETACIONES , UNA EN AL VALVULA NATIVA Y OTRO EN EL CATETER INTRACARDIACO DEL MARCAPASO DE LA SEÑORA. FUE DERIVADA A CIRUGIA CARDIOVASCULAR CON BUENA EVOLUCION.
Dr. Eduardo Gonzalez Caldera   Hace 1 año
Muy informativo, clara, completa útil para nuestra practica médica

gracias intramed
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2014